Loading data
GNPXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 0 USD | 0 USD | 0 USD | 0 USD |
| Research and development expense | 9.43 m USD | 10.54 m USD | 17.62 m USD | 11.51 m USD | 8.97 m USD |
| Operating profit | -15.52 m USD | -21.17 m USD | -31.06 m USD | -23.83 m USD | -20.67 m USD |
| Income tax expense | 0 USD | 2.65 k USD | 0 USD | 0 USD | — |
| Net income (reported basis) | -16.23 m USD | -21.39 m USD | -30.86 m USD | -23.74 m USD | -20.66 m USD |
| Net income attributable to common shareholders | -16.23 m USD | -21.39 m USD | -30.86 m USD | — | — |
| Basic earnings per share | -17.4 USD/share | -266.89 USD/share | -22.56 USD/share | -19.8 USD/share | -0.44 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.